Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aikaterini Semilietof

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 28, 2020
Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length PreferenceFabio Marino, Aikaterini Semilietof, Justine Michaux, et al.
Frontiers in Immunology|September 27, 2019
Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against MelanomaKalliopi Ioannidou, Olivier Randin, Aikaterini Semilietof, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Generation and Characterization of CAR-T CellsSarah Ash, Greta Maria Paola Giordano Attianese, Paris Kosti, et al.
The Journal of Clinical Investigation|June 3, 2024
Combining SiRPα decoy-coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cellsEvangelos Stefanidis, Aikaterini Semilietof, Julien Pujol, et al.
Journal for Immunotherapy of Cancer|January 11, 2025
Preclinical model for evaluating human TCRs against chimeric syngeneic tumorsAikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, et al.
Oncoimmunology|April 9, 2016
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancerSylvian Bron, Luc Henry, Eveline Faes-Van't Hull, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2026
Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homingRaphaël Porret, Fanny Lebreton, Eleonora Pace, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Cell Stem Cell|March 9, 2019
The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial ClearanceNicola Vannini, Vasco Campos, Mukul Girotra, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 28, 2020
Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length PreferenceFabio Marino, Aikaterini Semilietof, Justine Michaux, et al.
Frontiers in Immunology|September 27, 2019
Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against MelanomaKalliopi Ioannidou, Olivier Randin, Aikaterini Semilietof, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Generation and Characterization of CAR-T CellsSarah Ash, Greta Maria Paola Giordano Attianese, Paris Kosti, et al.
The Journal of Clinical Investigation|June 3, 2024
Combining SiRPα decoy-coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cellsEvangelos Stefanidis, Aikaterini Semilietof, Julien Pujol, et al.
Journal for Immunotherapy of Cancer|January 11, 2025
Preclinical model for evaluating human TCRs against chimeric syngeneic tumorsAikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, et al.
Oncoimmunology|April 9, 2016
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancerSylvian Bron, Luc Henry, Eveline Faes-Van't Hull, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2026
Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homingRaphaël Porret, Fanny Lebreton, Eleonora Pace, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Cell Stem Cell|March 9, 2019
The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial ClearanceNicola Vannini, Vasco Campos, Mukul Girotra, et al.
Pageof 1